These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 22845334)

  • 1. Advancing risk assessment for emerging infectious diseases for blood and blood products: proceedings of a public workshop.
    Gallagher LM; Ganz PR; Yang H; Kessler DA; O'Brien SF; Custer BS; Busch MP; Dodd RY; Stramer SL; Walderhaug MO; Forshee RA; Williams AE; Epstein JS; Anderson SA
    Transfusion; 2013 Feb; 53(2):455-63. PubMed ID: 22845334
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA workshop on emerging infectious diseases: evaluating emerging infectious diseases (EIDs) for transfusion safety.
    Atreya C; Nakhasi H; Mied P; Epstein J; Hughes J; Gwinn M; Kleinman S; Dodd R; Stramer S; Walderhaug M; Ganz P; Goodrich R; Tibbetts C; Asher D
    Transfusion; 2011 Aug; 51(8):1855-71. PubMed ID: 21392016
    [No Abstract]   [Full Text] [Related]  

  • 3. AABB contributions to plasma safety.
    Triulzi DJ
    Transfusion; 2012 May; 52 Suppl 1():5S-8S. PubMed ID: 22578373
    [No Abstract]   [Full Text] [Related]  

  • 4. Emerging infectious agents and the nation's blood supply: responding to potential threats in the 21st century.
    Glynn SA; Busch MP; Dodd RY; Katz LM; Stramer SL; Klein HG; Simmons G; Kleinman SH; Shurin SB;
    Transfusion; 2013 Feb; 53(2):438-54. PubMed ID: 22690676
    [No Abstract]   [Full Text] [Related]  

  • 5. Babesia: an emerging infectious threat in transfusion medicine.
    Lobo CA; Cursino-Santos JR; Alhassan A; Rodrigues M
    PLoS Pathog; 2013; 9(7):e1003387. PubMed ID: 23853577
    [No Abstract]   [Full Text] [Related]  

  • 6. Reflections on the emergence of chikungunya virus in the United States: time to revisit a successful paradigm for the safety of blood-derived therapies.
    Farrugia A; Kreil TR
    Transfusion; 2015 Jan; 55(1):224-6. PubMed ID: 25582241
    [No Abstract]   [Full Text] [Related]  

  • 7. Blood component recalls and market withdrawals: frequency, reasons, and management in the United States.
    Ramsey G
    Transfus Med Rev; 2013 Apr; 27(2):82-90. PubMed ID: 23375736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Blood safety in Mexico. Achievements and challenges].
    Sánchez-Guerrero SA
    Rev Invest Clin; 2011; 63(3):309-13. PubMed ID: 21888294
    [No Abstract]   [Full Text] [Related]  

  • 9. Transfusion safety: Where are we today?
    Luban NL
    Ann N Y Acad Sci; 2005; 1054():325-41. PubMed ID: 16339681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proceedings of the Food and Drug Administration public workshop on pathogen reduction technologies for blood safety 2018 (Commentary, p. 3026).
    Atreya C; Glynn S; Busch M; Kleinman S; Snyder E; Rutter S; AuBuchon J; Flegel W; Reeve D; Devine D; Cohn C; Custer B; Goodrich R; Benjamin RJ; Razatos A; Cancelas J; Wagner S; Maclean M; Gelderman M; Cap A; Ness P
    Transfusion; 2019 Sep; 59(9):3002-3025. PubMed ID: 31144334
    [No Abstract]   [Full Text] [Related]  

  • 11. The potential threat to blood transfusion safety of emerging infectious disease agents.
    Stramer SL
    Clin Adv Hematol Oncol; 2015 Jul; 13(7):420-2. PubMed ID: 26353036
    [No Abstract]   [Full Text] [Related]  

  • 12. Reasons for moving toward a patient-centric paradigm of clinical transfusion medicine practice.
    Vamvakas EC
    Transfusion; 2013 Apr; 53(4):888-901. PubMed ID: 22882177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The yield of temporary exclusion of blood donors, exposed to emerging infections abroad.
    Lieshout-Krikke RW; Zaaijer HL; Prinsze FJ
    Vox Sang; 2013 Jan; 104(1):12-8. PubMed ID: 22775433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First "themed issue" of Transfusion on thirty years of progress in blood safety since recognition of transfusion-associated AIDS.
    Busch MP; Ness PM
    Transfusion; 2013 Oct; 53(10 Pt 2):2357-8. PubMed ID: 24099405
    [No Abstract]   [Full Text] [Related]  

  • 15. Emerging viral infections‑-a potential threat for blood supply in the 21st century.
    de Mendoza C; Altisent C; Aznar JA; Batlle J; Soriano V
    AIDS Rev; 2012; 14(4):279-89. PubMed ID: 23258302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How we manage AB plasma inventory in the blood center and transfusion service.
    Yazer M; Eder AF; Land KJ
    Transfusion; 2013 Aug; 53(8):1627-33. PubMed ID: 23614505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Orthopoxviruses: infections in humans. Position of the Blood Working Group of the Federal Ministry of Health].
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Sep; 53(9):957-72. PubMed ID: 20853093
    [No Abstract]   [Full Text] [Related]  

  • 18. Emerging tick-borne diseases and blood safety: summary of a public workshop.
    Mohan KVK; Leiby DA
    Transfusion; 2020 Jul; 60(7):1624-1632. PubMed ID: 32208532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research opportunities in optimizing storage of red blood cell products.
    Wagner SJ; Glynn SA; Welniak LA;
    Transfusion; 2014 Feb; 54(2):483-94. PubMed ID: 23676138
    [No Abstract]   [Full Text] [Related]  

  • 20. Blood-Borne Pathogens: A Canadian Blood Services Centre for Innovation Symposium.
    Walsh GM; Shih AW; Solh Z; Golder M; Schubert P; Fearon M; Sheffield WP
    Transfus Med Rev; 2016 Apr; 30(2):53-68. PubMed ID: 26962008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.